Galmed Pharmaceuticals Ltd.
EOCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595353
No open-market purchases or sales by Galmed Pharmaceuticals Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $85.9K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Galmed Pharmaceuticals Ltd. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 22 | 25 | +3 |
| Shares | 2.52M | 2.59M | +63.1K (+2.5%) |
| Value | $1.70M | $803.6K | −$895.8K (−52.7%) |
New holders (5)
Institutions that held Galmed Pharmaceuticals Ltd. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 22,548 | $7.00K | 0.00% |
| Two Sigma Securities, LLC | 18,512 | $6.00K | 0.00% |
| BNP Paribas Arbitrage, SA | 14,290 | $4.45K | 0.00% |
| Ground Swell Capital, LLC | 13,028 | $4.00K | 0.01% |
| Jane Street Group, LLC | 13,904 | $4.00K | 0.00% |
Sold out (2)
Institutions that held Galmed Pharmaceuticals Ltd. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citigroup Inc | 3,700 | $3.00K |
| Simplex Trading, LLC | 2,750 | $1.00K |